CORONAVIRUS/NHRI develops rapid screening kit for SARS-CoV-2

04/02/2020 02:12 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
Pixabay image
Pixabay image

Taipei, April 2 (CNA) Taiwan's National Health Research Institutes (NHRI) announced Thursday that it has developed a rapid testing kit that can screen patients for SARS-CoV-2, the strain of conoravirus that causes COVID-19, in as little as 10-15 minutes.

The test involves inserting a cotton swab into the patient's nose to collect a fluid sample, then placing the swab onto a test strip, which changes color depending on what strain of virus the patient is infected with, the NHRI said.

Sytwu Huey-kang (司徒惠康), vice president of the NHRI, said that after more than a month of research, it was discovered that the antibodies of Severe Acute Respiratory Syndrome (SARS), which had a major outbreak in Taiwan in 2003, can also be used to screen for SARS-CoV-2.

Test results can be obtained in about 10-15 minutes, Sytwu said, noting that this type of kit is relatively cheaper than nucleic acid tests (NAT), a technique used to detect a particular nucleic acid sequence, such as identifying a particular species or subspecies of virus or bacteria.

Once available, the rapid tester could be used by frontline medical professionals to identify suspected COVID-19 patients as efficiently as possible, he explained.

The NHRI is expected to hold a meeting next week with several manufacturers in Taiwan to discuss the possibility for a trial production run of the testing kit, he said.

However, he stressed that it is still uncertain when the testing kit can begin clinical use.

(By Chang Ming-hsuan and Ko Lin)


View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.